Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate

J Neuroimmunol. 2020 Mar 15:340:577144. doi: 10.1016/j.jneuroim.2020.577144. Epub 2020 Jan 7.

Abstract

We report the case of a 25-year-old woman who developed temporal lobe epilepsy associated with systemic lupus erythematosus (SLE). Serum and cerebrospinal fluid samples showed high titers of anti-ribosomal P (anti-P) antibodies with negative anti-NMDAR antibodies. She was receiving prednisone and azathioprine, with normalization of SLE serum markers, but without changes in titers of anti-P antibodies. No seizure control was achieved using valproic acid, levetiracetam and lamotrigine. However, she had a selective response to topiramate, an AMPAR blocker, maintained during 6 years of follow-up. We discuss the pathophysiology of this autoimmune epilepsy associated with high titer anti-P antibodies.

Keywords: Anti-ribosomal P antibodies; Autoimmune epilepsy; Neuroimmunology; Refractory epilepsy; Systemic lupus erythematosus.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticonvulsants / therapeutic use*
  • Autoantibodies / immunology
  • Autoantigens / immunology
  • Drug Resistant Epilepsy / drug therapy*
  • Drug Resistant Epilepsy / etiology
  • Epilepsy, Temporal Lobe / drug therapy
  • Epilepsy, Temporal Lobe / etiology
  • Female
  • Humans
  • Lupus Vasculitis, Central Nervous System / complications*
  • Lupus Vasculitis, Central Nervous System / immunology
  • Ribosomal Proteins / immunology*
  • Topiramate / therapeutic use*

Substances

  • Anticonvulsants
  • Autoantibodies
  • Autoantigens
  • Ribosomal Proteins
  • Topiramate